iRhythm Holdings (IRTC) Research & Development (2015 - 2026)

iRhythm Holdings (IRTC) has reported Research & Development for 12 consecutive years, with $19.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 5.56% year-over-year to $19.8 million in Q2 2026; TTM through Jun 2026 was $83.3 million, a 7.73% increase from a year earlier, with the FY2025 full-year figure at $84.6 million, up 18.4% from the prior year.
• Research & Development was $19.8 million for Q2 2026 at iRhythm Holdings, down from $21.4 million in the prior quarter.
• Over five years, Research & Development peaked at $21.5 million in Q1 2025 and troughed at $10.5 million in Q1 2022.
• A 5-year average of $16.9 million and a median of $16.7 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 43.96% in 2024 and decreased 5.56% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $12.7 million in 2022, then increased by 21.63% to $15.4 million in 2023, then advanced by 23.77% to $19.1 million in 2024, then grew by 10.3% to $21.0 million in 2025, then slipped by 5.72% to $19.8 million in 2026.
• The last three Research & Development figures came in at $19.8 million (Q2 2026), $21.4 million (Q1 2026), and $21.0 million (Q4 2025), per Business Quant data.